脑卒中后抑郁的病因及发病机制研究进展

doi:10.3969/j.issn.1674-490X.2021.02.004

摘要/Abstract

摘要： 抑郁症是缺血性卒中最常见的并发症,对存活者的功能恢复和生活质量产生很大的负面影响。约1/3的人受到卒中后抑郁的影响,这使其成为一个严重的社会和公共卫生问题。合理预防及治疗卒中后抑郁需要对此疾病的病理生理因素有一个综合的认识。对脑卒中后抑郁的病因及发病机制进行详细综述可为以后此疾病的预防及治疗提供更全面、更系统的科学依据。

关键词: 脑卒中, 抑郁, 病因, 发病机制

Abstract: Depression is the most common complication of ischemic stroke, which has a great negative impact on the functional recovery and quality of life of survivors.About 1/3 people are affected by post-stroke depression, which makes it a serious social and public health problem.Reasonable prevention and treatment of post-stroke depression requires a comprehensive understanding of the pathophysiological factors of the disease.A detailed review of the etiology and pathogenesis of post-stroke depression can provide a more comprehensive and systematic scientific basis for the prevention and treatment of this disease in the future.

Key words: stroke, depression, etiology, pathogenesis

中图分类号:

R743

王子文, 高娟, 白艳梅, 张志强, 张金库. 脑卒中后抑郁的病因及发病机制研究进展[J]. 医学研究与教育, 2021, 38(2): 21-25.

参考文献

[1] MITCHELL A J, SHETH B, GILL J, et al.Prevalence and predictors of post-stroke mood disorders: a meta-analysis and meta-regression of depression, anxiety and adjustment disorder[J].Gen Hosp Psychiatry, 2017, 47: 48-60.DOI: 10.1016/j.genhosppsych.2017.04.001.
[2] CAI W, MUELLER C, LI Y J, et al.Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta-analysis[J].Ageing Res Rev, 2019, 50: 102-109.DOI: 10.1016/j.arr.2019.01.013.
[3] YUAN H W, WANG C X, ZHANG N, et al.Poststroke depression and risk of recurrent stroke at 1 year in a Chinese cohort study[J].PLoS One, 2012, 7(10): e46906.DOI: 10.1371/journal.pone.0046906.
[4] DONG L M, SÁNCHEZ B N, SKOLARUS L E, et al.Sex difference in prevalence of depression after stroke[J].Neurology, 2020, 94(19): e1973-e1983.DOI: 10.1212/wnl.0000000000009394.
[5] DONG L M, SÁNCHEZ B N, SKOLARUS L E, et al.Ethnic differences in prevalence of post-stroke depression[J].Circ Cardiovasc Qual Outcomes, 2018, 11(2): e004222.DOI: 10.1161/CIRCOUTCOMES.117.004222.
[6] FEI K Z, BENN E K, NEGRON R, et al.Prevalence of depression among stroke survivors: racial-ethnic differences[J].Stroke, 2016, 47(2): 512-515.DOI: 10.1161/STROKEAHA.115.010292.
[7] DE RYCK A, FRANSEN E, BROUNS R, et al.Psychosocial problems associated with depression at 18 months poststroke[J].Int J Geriatr Psychiatry, 2014, 29(2): 144-152.DOI: 10.1002/gps.3974.
[8] ANGUELOVA M, BENKELFAT C, TURECKI G.A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I.Affective disorders[J].Mol Psychiatry, 2003, 8(6): 574-591.DOI: 10.1038/sj.mp.4001328.
[9] MAK K K, KONG W Y, MAK A, et al.Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis[J].J Neurol Neurosurg Psychiatry, 2013, 84(3): 322-328.DOI: 10.1136/jnnp-2012-303791.
[10] KOHEN R, CAIN K C, MITCHELL P H, et al.Association of serotonin transporter gene polymorphisms with poststroke depression[J].Arch Gen Psychiatry, 2008, 65(11): 1296-1302.DOI: 10.1001/archpsyc.65.11.1296.
[11] ZHAO Q, GUO Y, YANG D, et al.Serotonin transporter gene 5-HTTLPR polymorphism as a protective factor against the progression of post-stroke depression[J].Mol Neurobiol, 2016, 53(3): 1699-1705.DOI: 10.1007/s12035-015-9120-7.
[12] WANG Y K, LIU H Y, JIANG Y, et al.Meta-analysis of 5-hydroxytryptamine transporter gene promoter region polymorphism and post-stroke depression[J].J Int Med Res, 2020, 48(6): 300060520925943.DOI: 10.1177/0300060520925943.
[13] GATT J M, NEMEROFF C B, DOBSON-STONE C, et al.Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety[J].Mol Psychiatry, 2009, 14(7): 681-695.DOI: 10.1038/mp.2008.143.
[14] KIM J M, STEWART R, BAE K Y, et al.Serotonergic and BDNF genes and risk of depression after stroke[J].J Affect Disord, 2012, 136(3): 833-840.DOI: 10.1016/j.jad.2011.09.029.
[15] JIN H J, PEI L, LI Y N, et al.Alleviative effects of fluoxetine on depressive-like behaviors by epigenetic regulation of BDNF gene transcription in mouse model of post-stroke depression[J].Sci Rep, 2017, 7(1): 14926.DOI: 10.1038/s41598-017-13929-5.
[16] ZHOU Z M, LU T T, XU G L, et al.Decreased serum brain-derived neurotrophic factor(BDNF)is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism[J].Clin Chem Lab Med, 2011, 49(2): 185-189.DOI: 10.1515/CCLM.2011.039.
[17] BERG C, BACKSTRÖM T, WINBERG S, et al.Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus[J].PLoS One, 2013, 8(1): e55053.DOI: 10.1371/journal.pone.0055053.
[18] JI X W, WU C L, WANG X C, et al.Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression[J].Exp Ther Med, 2014, 8(1): 159-164.DOI: 10.3892/etm.2014.1674.
[19] ZAHRAI A, VAHID-ANSARI F, DAIGLE M, et al.Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression[J].Transl Psychiatry, 2020, 10(1): 334.DOI: 10.1038/s41398-020-01008-9.
[20] ZHANG X F, ZOU W, YANG Y.Effects of IL-6 and cortisol fluctuations in post-stroke depression[J].Huazhong Univ Sci Technolog Med Sci, 2016, 36(5): 732-735.DOI: 10.1007/s11596-016-1653-0.
[21] SCHIEPERS O J, WICHERS M C, MAES M.Cytokines and major depression[J].Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29(2): 201-217.DOI: 10.1016/j.pnpbp.2004.11.003.
[22] KOO Y S, KIM H, PARK J H, et al.Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism contributes to poststroke depression induced in mice by ischemic stroke along with spatial restraint stress[J].Oxid Med Cell Longev, 2018, 2018: 2413841.DOI: 10.1155/2018/2413841.
[23] WU D, ZHANG G C, ZHAO C Y, et al.Interleukin-18 from neurons and microglia mediates depressive behaviors in mice with post-stroke depression[J].Brain Behav Immun, 2020, 88: 411-420.DOI: 10.1016/j.bbi.2020.04.004.
[24] CHEN Y, PU J C, LIU Y Y, et al.Pro-inflammatory cytokines are associated with the development of post-stroke depression in the acute stage of stroke: a meta-analysis[J].Top Stroke Rehabil, 2020: 1-10.DOI: 10.1080/10749357.2020.1755813.
[25] MEISEL C, SCHWAB J M, PRASS K, et al.Central nervous system injury-induced immune deficiency syndrome[J].Nat Rev Neurosci, 2005, 6(10): 775-786.DOI: 10.1038/nrn1765.
[26] KATON W J.Epidemiology and treatment of depression in patients with chronic medical illness[J].Dialogues Clin Neurosci, 2011, 13(1): 7-23.DOI: 10.31887/DCNS.2011.13.1/wkaton.
[27] WU R H, FENG C, XU Y, et al.Late-onset depression in the absence of stroke: associated with silent brain infarctions, microbleeds and lesion locations[J].Int J Med Sci, 2014, 11(6): 587-592.DOI: 10.7150/ijms.8025.
[28] WEI N, YONG W, LI X Y, et al.Post-stroke depression and lesion location: a systematic review[J].J Neurol, 2015, 262(1): 81-90.DOI: 10.1007/s00415-014-7534-1.
[29] GONG Q Y, HE Y.Depression, neuroimaging and connectomics: a selective overview[J].Biol Psychiatry, 2015, 77(3): 223-235.DOI: 10.1016/j.biopsych.2014.08.009.
[30] VAHID-ANSARI F, LAGACE D C, ALBERT P R.Persistent post-stroke depression in mice following unilateral medial prefrontal cortical stroke[J].Transl Psychiatry, 2016, 6(8): e863.DOI: 10.1038/tp.2016.124.
[31] ZHANG T, JING X, ZHAO X Q, et al.A prospective cohort study of lesion location and its relation to post-stroke depression among Chinese patients[J].J Affect Disord, 2012, 136(1/2): e83-e87.DOI: 10.1016/j.jad.2011.06.014.
[32] ZHANG L, SUI R B.Proton magnetic resonance spectroscopy study on the metabolism changes of cerebellum in patients with post-stroke depression[J].Cell Physiol Biochem, 2017, 41(4): 1393-1402.DOI: 10.1159/000467907.